• Streptavidin-FITC for Bacterial Adhesion Assays

  2026-08-31

  Use Streptavidin-FITC to convert biotinylated antibodies, probes, and cell-associated targets into measurable fluorescence across adhesion, imaging, and flow workflows. This guide connects the ST3GAL1–Fusobacterium nucleatum findings with practical assay design, controls, optimization, and troubleshooting.

• U 46619: From TP Signaling to Translational Insight

  2026-08-31

  U 46619, also known as 11,9 epoxymethano-prostaglandin H2, is a selective TP-receptor agonist that converts receptor activation into measurable platelet, vascular, renal, and blood-pressure phenotypes. This thought-leadership article places the compound within a translational framework, showing how concentration-dependent biology, orthogonal readouts, and careful separation from clinical anticoagulation can strengthen preclinical decision-making.

• Dual HER2–VEGFR-2 Targeting in Breast Cancer

  2026-08-30

  The 2026 reference study examines whether combining Lapatinib with the VEGFR tyrosine kinase inhibitor Telatinib can suppress invasive and angiogenic phenotypes in the HER2-negative MDA-MB-231 triple-negative breast cancer model. Its main contribution is a phenotype-first evaluation linking reduced invadopodia, cell proliferation, and two-dimensional tube formation to a potential HER-2/VEGFR-2 dual-targeting strategy, while also highlighting the need to distinguish functional drug response from direct receptor engagement.

• TAI-1: Hec1 Inhibitor Mechanism and Evidence

  2026-08-29

  TAI-1 is a potent small molecule Hec1 inhibitor that disrupts Hec1–Nek2 signaling, promotes mitotic errors, and induces apoptotic cell death in cancer models. Product data report a GI50 of 13.48 nM in K562 cells, while broader efficacy, biomarker, combination, and safety findings remain preclinical.

• Primidone and hPON1: Inhibition Study Insights

  2026-08-28

  The reference study purified human serum paraoxonase-1 and compared its inhibition by five antiepileptic drugs, identifying Primidone as a noncompetitive hPON1 inhibitor with an intermediate potency among the compounds tested. These findings broaden interpretation of antiepileptic drug biology and provide a biochemical basis for examining possible links between AED exposure, oxidative protection, and cardiovascular risk in epilepsy.

• Adipose-Neural Signaling in Cardiac Arrhythmia

  2026-08-28

  Fan et al. developed a stem cell-based coculture model showing that epicardial adipose tissue can activate sympathetic neurons through leptin and drive NPY/Y1R-dependent electrical instability in cardiomyocytes. The study connects this adipose-neural axis to NCX and CaMKII activity and supports its clinical relevance through EAT and coronary sinus blood measurements in patients with atrial fibrillation.

• Streptavidin-FITC for Mechanistic LNP Translation

  2026-08-27

  Streptavidin-FITC is more than a fluorescent tag: used strategically, it can help translational researchers connect biotinylated LNP disposition with surface charge, endo/lysosomal biology, and functional nucleic acid delivery. This thought-leadership guide outlines the mechanistic opportunity, validation framework, workflow parameters, competitive positioning, and limitations of applying fluorescein isothiocyanate conjugated streptavidin to delivery research.

• Demethyleneberberine in Con A–Induced Autoimmune Hepatitis

  2026-08-27

  The reference study showed that Demethyleneberberine (DMB) reduced concanavalin A-induced liver injury in mice while suppressing inflammatory-cell infiltration, cytokine production, oxidative stress, and activation of NF-κB and MAPK signaling. Its value is primarily mechanistic and preclinical: the work positions DMB as a candidate anti-autoimmune hepatitis agent, while also defining measurable endpoints for follow-up studies.

• Homoharringtonine Against SARS-CoV-2: Study Analysis

  2026-08-26

  The reference study presents homoharringtonine as a host-directed antiviral candidate that inhibits protein elongation and suppresses replication across tested coronaviruses. Its progression from cell-based assays to mouse experiments and exploratory human administration is valuable for epidemic preparedness, while the limited clinical evidence requires cautious interpretation.

• SB-505124 hydrochloride: Applied TGF-β Workflows

  2026-08-26

  Build cleaner TGF-β/activin experiments with a reversible ALK4/5/7 inhibitor, from Smad phosphorylation assays to fibrosis and glaucoma filtration models. A structured workflow also shows how to test, without overclaiming, whether receptor-proximal signaling contributes to cancer-cell mechanics.

• Berberrubine Chloride: A Translational Control Point

  2026-08-25

  Berberrubine chloride is more than a natural-product cytotoxicity probe: its activity across IMPDH2, TrxR, GSTM2, inflammatory signaling, and urate transport creates a mechanism-led framework for translational research. This article explains how to validate those mechanisms, manage experimental liabilities, and position the compound across oncology, inflammation, and hyperuricemia studies.

• Mitomycin C in Glioma EMT Assay Design

  2026-08-25

  Mitomycin C can do more than trigger DNA damage in cancer research: it can serve as a carefully controlled perturbation for studying proliferation, invasion, and EMT. This article integrates Mitomycin C pharmacology with BAF53a-centered glioma findings to improve assay interpretation and experimental design.

• FCCP Workflows for Mitochondrial Biology

  2026-08-24

  Build more informative mitochondrial experiments with FCCP by separating acute respiration measurements from longer HIF and viability studies. This practical guide connects FCCP perturbation with autophagy-activator screening, HR-LCMS/MS dereplication, and reproducible troubleshooting.

• BIBP 3226 Trifluoroacetate in Arrhythmia Research

  2026-08-24

  BIBP 3226 trifluoroacetate is a receptor-level tool for dissecting NPY/Y1R signaling in adipose-neural arrhythmia models. This article translates recent mechanistic findings into practical assay and interpretation decisions.

• Neticonazole Hydrochloride in Cell Assays

  2026-08-23

  A scenario-driven guide to using Neticonazole Hydrochloride (SKU C8715) in viability, proliferation, antifungal, and exploratory colorectal cancer assays. It connects mechanism, stock preparation, controls, interpretation, and vendor-selection considerations to improve experimental comparability without overstating preclinical evidence.

8069 records 1/538 page Next 12345 下5页 Last page